(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-30 View latest technical analysis
10 day averaged volume of Blueprint Medicines is 341200
| Date | Daily Closing Price | Open | High | Low | Volume |
| 30 Fri Aug 2024 | 95.54 | 94.52 | 95.67 | 93.14 | 0.9 times |
| 30 Fri Aug 2024 | 95.54 | 94.52 | 95.67 | 93.14 | 0.9 times |
| 29 Thu Aug 2024 | 93.61 | 93.64 | 95.19 | 93.28 | 0.751 times |
| 28 Wed Aug 2024 | 92.75 | 93.15 | 93.90 | 92.42 | 1.327 times |
| 27 Tue Aug 2024 | 93.14 | 94.32 | 94.53 | 92.23 | 1.093 times |
| 26 Mon Aug 2024 | 95.08 | 94.55 | 95.40 | 93.43 | 0.829 times |
| 23 Fri Aug 2024 | 94.55 | 94.34 | 95.39 | 93.59 | 0.875 times |
| 22 Thu Aug 2024 | 93.51 | 94.84 | 96.21 | 93.12 | 0.772 times |
| 21 Wed Aug 2024 | 94.78 | 93.73 | 95.85 | 93.26 | 1.318 times |
| 20 Tue Aug 2024 | 93.20 | 94.18 | 95.20 | 92.92 | 1.03 times |
My analysis of stock is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if stock stays above 95.1, but if it comes below 95.1, then a intra day sell could be more profitable.
If you take a sell trade below 95.1, then use 95.1 as stoploss and 93.76 as target. However if you take a buy trade in stock , then use 95.1 as stoploss and 96.6 as target.
Share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Target | 84.33 |
| Downside Target | 89.35 |
| Upside Target | 95.67 |
| Upside Target | 96.21 |
| Upside Target | 97.00 |
| Upside Target | 100.67 |
| Upside Target | 106.56 |
| Upside Target | 108.40 |
| Upside Target | 111.02 |
| Upside Target | 111.42 |
| Upside Target | 121.90 |
Intraday share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Intraday Target | 93.9 |
| Downside Intraday Target | 92.25 |
| Upside Intraday Target | 96.43 |
| Upside Intraday Target | 97.31 |
| Downside Intraday Target | 94.78 |
Weekly technical analysis of Blueprint Medicines (BPMC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 30 Fri Aug 2024 | 95.54 | 94.52 | 95.67 | 93.14 | 0.184 times |
| 30 Fri Aug 2024 | 95.54 | 94.55 | 95.67 | 92.23 | 0.961 times |
| 23 Fri Aug 2024 | 94.55 | 93.35 | 96.21 | 92.77 | 0.599 times |
| 16 Fri Aug 2024 | 93.49 | 94.44 | 96.21 | 91.55 | 0.608 times |
| 09 Fri Aug 2024 | 93.90 | 90.00 | 95.91 | 89.35 | 0.68 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 30 Fri Aug 2024 | 95.54 | 106.51 | 108.40 | 89.35 | 1.157 times |
| 31 Wed Jul 2024 | 108.30 | 107.68 | 121.90 | 106.56 | 1.132 times |
| 28 Fri Jun 2024 | 107.78 | 106.43 | 111.42 | 100.67 | 0.902 times |
| 31 Fri May 2024 | 105.56 | 91.44 | 111.02 | 90.85 | 1.009 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Blueprint Medicines in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 94.11 and Blueprint Medicines (BPMC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Blueprint Medicines in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 94.11 and Blueprint Medicines (BPMC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.